The Roots Analysis team is putting in its best effort to offer our clients / readers a reliable source of information, regarding how the pharmaceutical and biotech sectors are coping in the midst of the COVID-19 pandemic. Our intention is to generate realistic insights, based on a variety of factors, which are anticipated to influence both prevalent and future market dynamics. Reach out to us for any help.

Global Antibody Purification Services Market by Company Size (Small-sized, Mid-sized and Large / Very Large), Type of Antibody (Monoclonal, Polyclonal and Others), Purification Method (Physico-Chemical, Class Specific and Antigen Affinity), End User (Pharmaceutical / Biotechnology Companies and Diagnostic Laboratories) and by Key Geographical Regions (North America, Europe, Asia-Pacific, Latin America and Middle-East and North Africa), 2021-2030

  • Lowest Price Guaranteed From USD 5,499

  • Published
    January 2021

  • Pages
    275

  • View Count
    2156

Example Insights

Antibody-Purification-Services-Market-Context Antibody-Purification-Services-Market-List-of-Antibody-Purification-Service-Providers Antibody-Purification-Services-Market-Distribution
Antibody-Purification-Services-Market-Company-Landscape Antibody-Purification-Services-Market-3D-Bubble-Analysis Antibody-Purification-Services-Market-Regional-Capability-Analysis
Antibody-Purification-Services-Market-List-of-Antibody-Contract-Manufacturers Antibody-Purification-Services-Market-Distribution-by-Purification-Method Antibody-Purification-Services-Market-Current-and-Future-Market-Size

Overview

Orthoclone OKT3® was the first monoclonal antibody-based drug (approved in 1986). As of today, more than 100 such products are available for therapeutic use across different geographies. Recently, Margenza™ (December 2020), Danyelza® (November 2020), Adakveo® (November 2019), Beovu® (October 2019), SKYRIZI™ (April 2019) and EVENITY™ (April 2019), were approved by the USFDA. Owing to their specificity for a target biomolecule (antigen) and favorable safety profile (compared to small molecule drugs), antibody-based interventions presently make up the largest class of biologic drugs. This trend is unlikely to change as multiple advanced variants of these drugs, such as bispecific antibodies and antibody fragments-based products, have been developed and several pharmacological leads based on these relatively novel constructs, are under evaluation. However, as is the case with all biologics, the production of antibodies is also a complex process. Specifically, antibody purification, which is one of the most crucial steps downstream of the manufacturing process, is a cost intensive operation. The investment of both effort and capital at this stage of production is justified because any impurity, or unwanted antibody molecule, poses a serious threat to not only therapeutic efficacy but also to the safety of patients. A variety of physiochemical approaches, including ammonium sulphate precipitation, hydrophobic interaction chromatography, ion-exchange chromatography and size exclusion chromatography techniques, are used to purify antibodies. 

With the surge in demand for antibodies across research, diagnostic and therapeutic applications, there is now an urgent, parallel need to optimize production throughput. In this context, the purification aspect needs to be handled with extra caution, considering the dangers associated with contaminated medical products. Owing to prohibitive capital investments on purification infrastructure and the required expertise, not all therapy developers are able to establish in-house capabilities, especially at the larger (clinical and commercial) scales. Outsourcing is, therefore, a widely used operational model in this industry. The antibody purification services market today has evolved into a competitive domain, featuring the presence of start-ups, mid-sized companies and several established firms, some of which claim to offer end-to-end downstream processing solutions, as well. Moreover, such service-focused companies generally ensure that they have the latest upgrades in equipment and infrastructure, in order to differentiate themselves from the contemporary competition. Given the growing trend of outsourcing in the healthcare industry and the ongoing efforts of service providers to further improve / expand their respective portfolios, we believe the antibody purification services market is likely to evolve at a steady pace, till 2030.

Scope of the Report

The "Global Antibody Purification Services Market, 2020-2030" report features an extensive study on the current market landscape, offering an informed opinion on the future opportunities in this industry, over the next ten years. The study underlines an in-depth analysis of the purification services for antibodies offered by service providers, which are intended for use in various R&D and / or therapeutic purposes. In addition to other elements, it includes:

  • A detailed review of the overall landscape of the antibody purification services market, highlighting the contributions of service providers, along with the information on year of establishment, company size, location of headquarters, sources of antibodies and type of antibody (monoclonal, polyclonal and others), type of purification method (physio chemical, class specific and antigen affinity purification), application area (diagnostics, therapeutics and research) and end user (hospitals and clinics, industry and research institutes). 
  • A company competitiveness analysis, highlighting prominent antibody purification service providers based in different regions, taking into consideration supplier strength (in terms of experience and size of the service provider), and portfolio specifications (sources of antibody, type of antibody, type of purification method, application and end user).
  • Elaborate profiles of antibody purification service providers. Each company profile features a brief overview of the company, its financial information (if available), antibody purification service portfolio and an informed future outlook.
  • An insightful regional capability assessment framework, highlighting the comparison of the capabilities of service providers (based on source of antibody, purification method, application area, purification demand and the market size) across different geographies.
  • Informed estimates of the annual commercial and clinical demand for antibodies, based on various relevant parameters, such as target patient population, dosing frequency and dose strength.
  • A case study on market landscape of companies, offering contract services for the manufacturing of antibodies, including information on year of establishment, company size, scale of operation (preclinical, clinical and commercial), location of headquarters, number of manufacturing facilities and location of these facilities, type of antibody manufactured (monoclonal antibodies, bispecific antibodies and polyclonal antibodies), type of expression systems used (mammalian, microbial and others), and affiliations to regulatory agencies

One of the key objectives of the report was to estimate the existing market size and the future opportunities within the antibody purification services market. Based on multiple parameters, such as projected growth of overall antibody-based products market, cost of goods sold and direct manufacturing costs, we have developed informed estimates on the financial evolution of the market over the period 2020-2030. The report also provides details on the likely distribution of the current and forecasted opportunity across [A] company size (small, mid-sized and large / very large), [B] type of  antibody (monoclonal, polyclonal and others), [C] type of purification method (physio chemical, class specific and antigen affinity purification), [D] end user (pharmaceutical and biotechnology companies, and diagnostic laboratories) and [E] key geographies (North America, Europe, Asia Pacific, Middle East and North Africa (MENA), and Latin America (LATAM)).
To account for the uncertainties associated with this industry and to add robustness to our model, we have provided three forecast scenarios, portraying the conservative, base and optimistic tracks of the market's evolution.

All actual figures have been sourced and analyzed from publicly available information forums and primary research discussions. Financial figures mentioned in this report are in USD, unless otherwise specified.

Key Questions Answered

  • Who are the leading players offering antibody purification services?
  • What is the current geographical distribution of antibody purification service providers?
  • What are the common purification methods, end users and application areas offered by the service providers?
  • What are the key factors that are likely to influence the evolution of this market?
  • What is the likely demand in the antibody purification services domain?
  • How is the current and future opportunity likely to be distributed across key market segments?
  • What are the anticipated future trends in antibody purification services market?

Contents

Chapter Outlines

Chapter 2 is an executive summary of the insights captured in our research. The summary offers a high-level view on the likely evolution of the antibody purification services market in the mid to long term.

Chapter 3 In this chapter, we have briefly discussed the types of antibody purification methods. It highlights the need for outsourcing of antibody purification and the guidelines for selecting a service provider.

Chapter 4 provides an overview of the overall antibody purification services landscape, providing information on over 180 service providers that are currently active in this domain. It features an in-depth analysis of the market, based on year of establishment, company size, location of headquarters, sources of antibodies and type of antibody (monoclonal, polyclonal and others), type of purification method (physio chemical, class specific and antigen affinity purification), application area (diagnostics, therapeutics and research) and end user (hospitals and clinics, industry and research institutes).

Chapter 5 provides an insightful competitiveness analysis of the antibody purification service providers that we came across during our research. The analysis compares the companies on the basis of supplier strength (in terms of experience and employee size of the service provider) and service portfolio strength (in terms of source of antibodies purified, type of antibody, type of purification method, application areas and end user).

Chapter 6 features detailed profiles of the key players active in the antibody purification services domain. Each company profile features a brief overview of the company, its financial information (if available), antibody purification service portfolio and an informed future outlook.

Chapter 7 chapter presents a detailed regional capability assessment framework, highlighting comparison of the capabilities of service providers (based on source of antibody, purification method, application area, purification demand and the market size) across different geographies.

Chapter 8 provides informed estimates of the annual commercial and clinical demand for antibodies, based on various relevant parameters, such as target patient population, dosing frequency and dose strength.

Chapter 9 presents a comprehensive market forecast analysis, highlighting the likely growth of antibody purification services market till the year 2030. The chapter provides likely distribution of the projected future opportunity based on company size (small, mid-sized and large / very large sized), type of antibody (monoclonal, polyclonal and others), type of purification method (physio chemical, class specific and antigen affinity purification), end user (pharmaceutical and biotechnology companies, and diagnostic laboratories) and key geographies (North America, Europe, Asia Pacific, MENA and LATAM).

Chapter 10 presents a detailed case study on market landscape of companies that offer contract services for manufacturing antibodies, including information on year of establishment, company size, scale of operation (preclinical, clinical and commercial), location of headquarters, number of manufacturing facilities and location of these facilities, type of antibody manufactured (monoclonal antibodies, bispecific antibodies and polyclonal antibodies), type of expression systems used (mammalian, microbial and others), and affiliations to regulatory agencies.

Chapter 11 is a collection of interview transcripts of the discussions held with key stakeholders in the industry. 

Chapter 12 summarizes the entire report. It presents a list of key takeaways and offers our independent opinion on the current market scenario.

Chapter 13 is an appendix, which provides tabulated data and numbers for all the figures in the report.

Chapter 14 is an appendix, which provides the list of companies and organizations mentioned in the report.

Table Of Contents

1. PREFACE
1.1. Scope of the Report
1.2 Research Methodology
1.3. Key Questions Answered
1.4. Chapter Outlines

2. EXECUTIVE SUMMARY

3. INTRODUCTION
3.1. Chapter Overview
3.2 Types of Antibody Purification Methods

3.3. Outsourcing Antibody Manufacturing and Purification Operations
3.3.1. Need for Outsourcing
3.3.2 Advantages of Outsourcing Purification Services
3.3.3 Guidelines for Selecting a Service Provider

3.3. Growth Drivers and Roadblocks

4. MARKET LANDSCAPE
4.1. Chapter Overview
4.2. Antibody Purification Service Providers: Overall Market Landscape
4.2.1. Analysis by Year of Establishment
4.2.2. Analysis by Company Size
4.2.3. Analysis by Location of Headquarters
4.2.4. Analysis by Source of Antibody
4.2.5. Analysis by Type of Antibody
4.2.6. Analysis by Type of Purification Method
4.2.7. Analysis by Application Area
4.2.8. Analysis by Type of Physio Chemical Antibody Purification Method
4.2.9. Analysis by Type of Class-Specific Antibody Purification Method
4.2.10. Analysis by Application Area
4.2.11. Analysis by End User

5. COMPANY COMPETITIVENESS ANALYSIS
5.1. Chapter Overview
5.2. Methodology
5.3. Assumptions and Key Input Parameters
5.4. Company Competitiveness Analysis: Antibody Purification Service Providers in North America
5.5. Company Competitiveness Analysis: Antibody Purification Service Providers in Europe
5.6. Company Competitiveness Analysis: Antibody Purification Service Providers in Asia-Pacific and Rest of the World

6. COMPANY PROFILES
6.1. Chapter Overview

6.2. Antibody Purification Service Providers in North America
6.2.1. Antibody Research
6.2.1.1. Company Overview
6.2.1.2. Antibody Purification Service Portfolio

6.2.2. Bio-synthesis
6.2.2.1. Company Overview
6.2.2.2. Service Portfolio

6.2.3. Genscript Biotech
6.2.3.1. Company Overview
6.2.3.2. Antibody Purification Service Portfolio
6.2.3.3. Recent Developments and Future Outlook

6.2.4 ProSci
6.2.4.1. Company Overview
6.2.4.2. Antibody Purification Service Portfolio
6.2.4.3. Recent Developments and Future Outlook

6.2.5. QED Bioscience
6.2.5.1. Company Overview
6.2.5.2. Antibody Purification Service Portfolio
6.2.5.3. Recent Developments and Future Outlook

6.2.6. SouthernBiotech
6.2.6.1. Company Overview
6.2.6.2. Antibody Purification Service Portfolio
6.2.6.3. Recent Developments and Future Outlook

6.2.7. Thermo Fisher Scientific
6.2.7.1. Company Overview
6.2.7.2. Financial Information
6.2.7.3. Antibody Purification Service Portfolio
6.2.7.4. Recent Developments and Future Outlook

6.2.8. Virusys
6.2.8.1. Company Overview
6.2.8.2. Antibody Purification Service Portfolio

6.3. Antibody Purification Service Providers in Europe
6.3.1. 2BScientific
6.3.1.1. Company Overview
6.3.1.2. Antibody Purification Service Portfolio
6.3.1.3. Recent Developments and Future Outlook

6.3.2. BBI Solutions
6.3.2.1. Company Overview
6.3.2.2. Service Portfolio
6.3.2.3. Antibody Purification Service Portfolio
6.3.2.4. Recent Developments and Future Outlook

6.3.3. Covalab
6.3.3.1. Company Overview
6.3.3.2. Antibody Purification Service Portfolio
6.3.3.3. Recent Developments and Future Outlook

6.3.4 RD-Biotech
6.3.4.1. Company Overview
6.3.4.2. Antibody Purification Service Portfolio
6.3.4.3. Recent Developments and Future Outlook

6.4. Antibody Purification Service Providers in Asia-Pacific and the Rest of the World
6.4.1. Allele Life Sciences
6.4.1.1. Company Overview
6.4.1.2. Antibody Purification Service Portfolio
6.4.1.3. Recent Developments and Future Outlook

6.4.2. Detai Bio-Tech
6.4.2.1. Company Overview
6.4.2.2. Service Portfolio
6.4.2.3. Antibody Purification Service Portfolio
6.4.2.4. Recent Developments and Future Outlook

6.4.3. Syngene
6.4.3.1. Company Overview
6.4.3.2. Financial Information
6.4.3.3. Antibody Purification Service Portfolio
6.4.3.4. Recent Developments and Future Outlook

7. REGIONAL CAPABILITY ANALYSIS 
7.1. Chapter Overview
7.2. Regional Capability Analysis: Antibody Purification Service Providers

7.2.1 Capabilities of Antibody Purification Service Providers based in North America
7.2.1.1. Antibody Purification Service Providers based in North America: Analysis by Company Size
7.2.1.2. Antibody Purification Service Providers based in North America: Analysis by Type of Antibody Purified
7.2.1.3. Antibody Purification Service Providers based in North America: Analysis by Type of Antibody Purified
7.2.1.4. Antibody Purification Service Providers based in North America: Analysis by Application Area
7.2.1.5. Antibody Purification Service Providers based in North America: Demand Analysis
7.2.1.6. Antibody Purification Service Providers based in North America: Opportunity Analysis

7.2.2. Capabilities of Antibody Purification Service Providers based in Europe
7.2.2.1. Antibody Purification Service Providers based in Europe: Analysis by Company Size
7.2.2.2. Antibody Purification Service Providers based in Europe: Analysis by Type of Antibody Purified
7.2.2.3. Antibody Purification Service Providers based in Europe: Analysis by Type of Antibody Purified
7.2.2.4. Antibody Purification Service Providers based in Europe: Analysis by Application Area
7.2.2.5. Antibody Purification Service Providers based in Europe: Demand Analysis
7.2.2.6. Antibody Purification Service Providers based in Europe: Opportunity Analysis

7.2.3. Capabilities of Antibody Purification Service Providers based in Asia-Pacific and the Rest of the World
7.2.3.1. Antibody Purification Service Providers based in Asia-Pacific and the Rest of the World: Analysis by Company Size
7.2.3.2. Antibody Purification Service Providers based in Asia-Pacific and the Rest of the World: Analysis by Type of Antibody Purified
7.2.3.3. Antibody Purification Service Providers based in Asia-Pacific and the Rest of the World: Analysis by Type of Antibody Purified
7.2.3.4. Antibody Purification Service Providers based in Asia-Pacific and the Rest of the World: Analysis by Application Area
7.2.3.5. Antibody Purification Service Providers based in Asia-Pacific and the Rest of the World: Demand Analysis
7.2.3.6. Antibody Purification Service Providers based in Asia-Pacific and the Rest of the World: Opportunity Analysis

8. DEMAND ANALYSIS
8.1. Chapter Overview
8.2. Assumptions and Methodology
8.3. Antibody Purification Market: Overall Annual Demand
8.3.1. Analysis by Scale of Operation
8.3.2. Analysis by Geography

9. MARKET FORECAST AND OPPORTUNITY ANALYSIS 
9.1. Chapter Overview
9.2. Key Assumptions and Forecast Methodology
9.3. Global Antibody Purification Services Market, 2020-2030
9.3.1. Global Antibody Purification Services Market, 2020- 2030: Distribution by Company Size
9.3.2. Global Antibody Purification Services Market, 2020- 2030: Distribution by Type of Antibody
9.3.3. Global Antibody Purification Services Market, 2020-2030: Distribution by Type of Purification Method
9.3.4. Global Antibody Purification Services Market, 2020- 2030: Distribution by End User
9.3.5. Global Antibody Purification Services Market, 2020-2030: Geographical Distribution

9.4. Antibody Purification Services Market in North America, 2020-2030
9.4.1. Antibody Purification Services Market in North America, 2020-2030: Share of Small Companies
9.4.2. Antibody Purification Services Market in North America, 2020-2030: Share of Mid-sized Companies
9.4.3. Antibody Purification Services Market in North America, 2020-2030: Share of Large / Very Large Companies
9.4.4. Antibody Purification Services Market in North America, 2020-2030: Distribution by Type of Purification Method
9.4.5. Antibody Purification Services Market in North America, 2020-2030: Distribution by Type of Antibody
9.4.6. Antibody Purification Services Market in North America, 2020-2030: Distribution by End User

9.5. Antibody Purification Services Market in Europe, 2020-2030
9.5.1. Antibody Purification Services Market in Europe, 2020-2030: Share of Small Companies
9.5.2. Antibody Purification Services Market in Europe, 2020-2030: Share of Mid-Sized Companies
9.5.3. Antibody Purification Services Market in Europe, 2020-2030: Share of Large / Very Large Companies
9.5.4. Antibody Purification Services Market in Europe, 2020-2030: Distribution by Type of Purification Method
9.5.5. Antibody Purification Services Market in Europe, 2020-2030: Distribution by Type of Antibody
9.5.6. Antibody Purification Services Market in Europe, 2020-2030: Distribution by End User

9.6. Antibody Purification Services Market in Asia Pacific, 2020-2030
9.6.1. Antibody Purification Services Market in Asia Pacific, 2020-2030: Share of Small Companies
9.6.2. Antibody Purification Services Market in Asia Pacific, 2020-2030: Share of Mid-Sized Companies
9.6.3. Antibody Purification Services Market in Asia Pacific, 2020-2030: Share of Large / Very Large Companies
9.6.4. Antibody Purification Services Market in Asia Pacific, 2020-2030: Distribution by Type of Purification Method
9.6.5. Antibody Purification Services Market in Asia Pacific, 2020-2030: Distribution by Type of Antibody
9.6.6. Antibody Purification Services Market in Asia Pacific, 2020-2030: Distribution by End User

9.7. Antibody Purification Services Market in Latin America, 2020-2030
9.7.1. Antibody Purification Services Market in Latin America, 2020-2030: Share of Small Companies
9.7.2. Antibody Purification Services Market in Latin America, 2020-2030: Share of Mid-Sized Companies
9.7.3. Antibody Purification Services Market in Latin America, 2020-2030: Share of Large / Very Large Companies
9.7.4. Antibody Purification Services Market in Latin America, 2020-2030: Distribution by Type of Purification Method
9.7.5. Antibody Purification Services Market in Latin America, 2020-2030: Distribution by Type of Antibody
9.7.6. Antibody Purification Services Market in Latin America, 2020-2030: Distribution by End User

9.8. Antibody Purification Services Market in Middle East and North Africa, 2020-2030
9.8.1. Antibody Purification Services Market in Middle East and North Africa, 2020-2030: Share of Small Companies
9.8.2. Antibody Purification Services Market in Middle East and North Africa, 2020-2030: Share of Mid-Sized Companies
9.8.3. Antibody Purification Services Market in Middle East and North Africa, 2020-2030: Share of Large / Very Large Companies
9.8.4. Antibody Purification Services Market in Middle East and North Africa, 2020-2030: Distribution by Type of Purification Method
9.8.5. Antibody Purification Services Market in Middle East and North Africa, 2020-2030: Distribution by Type of Antibody
9.8.6. Antibody Purification Services Market in Middle East and North Africa, 2020-2030: Distribution by End User

10. CASE STUDY: ANTIBODY CONTRACT MANUFACTURING MARKET LANDSCAPE
10.1. Chapter Overview
10.2. Antibody Contract Manufacturers: Overall Market Landscape
10.2.1. Analysis by Year of Establishment
10.2.2. Analysis by Company Size
10.2.3. Analysis by Scale of Operation
10.2.4. Analysis by Location of Headquarters
10.2.5. Analysis by Type of Antibody
10.2.6. Analysis by Expression System Used
10.2.7. Analysis by Regulatory Accreditations / Certifications

11. CONCLUDING REMARKS

12. EXECUTIVE INSIGHTS
12.1. Chapter Overview
12.2. Abveris
12.2.1. Company Snapshot
12.2.2. Interview Transcript

13. APPENDIX 1: LIST OF COMPANIES AND ORGANIZATIONS

14. APPENDIX 2: TABULATED DATA

List Of Figures

Figure 3.1 Methods Used for Physicochemical Fractionation
Figure 3.2 Steps Involved in Antigen-Specific Affinity Antibody Purification
Figure 3.3 Types of Third-Party Service Providers
Figure 3.4 Guidelines for Selecting an Antibody Purification Service Provider
Figure 3.5 Growth Drivers and Roadblocks for Antibody Manufacturing and Purification Operations
Figure 4.1 Antibody Purification Service Providers: Distribution by Year of Establishment
Figure 4.2 Antibody Purification Service Providers: Distribution by Company Size
Figure 4.3 Antibody Purification Service Providers: Distribution by Location of Headquarters
Figure 4.4 World Map Representation: Analysis by Geography
Figure 4.5 Antibody Purification Service Providers: Distribution by Availability of Contract Manufacturing Services
Figure 4.6 Antibody Purification Service Providers: Distribution by Type of Antibody Purified
Figure 4.7 Antibody Purification Service Providers: Distribution by Source of Antibody
Figure 4.8 Antibody Purification Service Providers: Distribution by Type of Purification Method
Figure 4.9 Antibody Purification Service Providers: Distribution by Type of Physio Chemical Purification Method
Figure 4.10 Antibody Purification Service Providers: Distribution by Type of Class Specific Purification Method
Figure 4.11 Antibody Purification Service Providers: Distribution by Application Area
Figure 4.12 Antibody Purification Service Providers: Distribution by End User
Figure 4.13 Antibody Purification Service Providers: Distribution by Type of Antibody and End User
Figure 5.1 Company Competitiveness: Antibody Purification Service Providers in North America
Figure 5.2 Company Competitiveness: Antibody Purification Service Providers in Europe
Figure 5.3 Company Competitiveness: Antibody Purification Service Providers in Asia-Pacific and the Rest of the World
Figure 5.5 Competitiveness Analysis of Antibody Purification Service: Competitiveness Score of Top Service Providers
Figure 6.1 Thermo Fisher Scientific: Annual Revenues, FY 2015-Q3 2020 (USD Billion)
Figure 6.2 Syngene: Annual Revenues, FY 2016-FY 2020 (INR Billion)
Figure 7.1 Antibody Purification Service Providers: Geographical Landscape
Figure 7.2 Antibody Purification Service Providers based in North America: Logo Landscape
Figure 7.3 Antibody Purification Service Providers based in North America: Distribution by Type of Antibody
Figure 7.4 Antibody Purification Service Providers based in North America: Distribution by Type of Purification Method
Figure 7.5 Antibody Purification Service Providers based in North America: Distribution by Application Area
Figure 7.6 Antibody Purification Service Providers based in North America: Distribution by Annual Demand for Antibodies (in Kilograms)
Figure 7.7 Antibody Purification Service Providers based in North America: Distribution by Size of the Market, 2020-2030 (USD Billion)
Figure 7.8 Antibody Purification Service Providers based in Europe: Logo Landscape
Figure 7.9 Antibody Purification Service Providers based in Europe: Distribution by Type of Antibody
Figure 7.10 Antibody Purification Service Providers based in Europe: Distribution by Type of Purification Method
Figure 7.11 Antibody Purification Service Providers based in Europe: Distribution by Application Area
Figure 7.12 Antibody Purification Service Providers based in Europe: Distribution by Annual Demand for Antibodies (in Kilograms)
Figure 7.13 Antibody Purification Service Providers based in Europe: Distribution by Size of the Market, 2020-2030 (USD Billion)
Figure 7.14 Antibody Purification Service Providers based in Asia-Pacific and the Rest of the World: Logo Landscape
Figure 7.15 Antibody Purification Service Providers based in Asia-Pacific and the Rest of the World: Distribution by Type of Antibody
Figure 7.16 Antibody Purification Service Providers based in Asia-Pacific and the Rest of the World: Distribution by Type of Purification Method
Figure 7.17 Antibody Purification Service Providers based in Asia-Pacific and the Rest of the World: Distribution by Application Area
Figure 7.18 Antibody Purification Service Providers based in Asia-Pacific and the Rest of the World: Distribution by Annual Demand for Antibodies (in Kilograms)
Figure 7.19 Antibody Purification Service Providers based in Asia-Pacific and the Rest of the World: Distribution by Size of the Market, 2020-2030 (USD Billion)
Figure 7.19 Regional Capability Assessment
Figure 8.1 Demand Analysis: Annual Demand for Antibodies (in Kilograms)
Figure 8.2 Demand Analysis: Distribution by Scale of Operation (in Kilograms)
Figure 8.3 Demand Analysis: Distribution by Geographical Location
Figure 9.1 Global Antibody Purification Services Market, 2020-2030 (USD Billion)
Figure 9.2 Global Antibody Purification Services Market, 2020- 2030: Distribution by Company Size (USD Billion)
Figure 9.3 Global Antibody Purification Services Market, 2020-2030: Distribution by Type of Purification Method (USD Billion)
Figure 9.4 Global Antibody Purification Services Market, 2020- 2030: Distribution by Type of Antibody (USD Billion)
Figure 9.5 Global Antibody Purification Services Market, 2020- 2030: Distribution by End User (USD Billion)
Figure 9.6 Global Antibody Purification Services Market, 2020-2030: Distribution by Geography (USD Billion)
Figure 9.7 Antibody Purification Services Market in North America, 2020-2030 (USD Billion)
Figure 9.8 Antibody Purification Services Market in North America, 2020-2030: Share of Small Companies (USD Billion)
Figure 9.9 Antibody Purification Services Market in North America, 2020-2030: Share of Mid-sized Companies (USD Billion)
Figure 9.10 Antibody Purification Services Market in North America, 2020-2030: Share of Large / Very Large Companies (USD Billion)
Figure 9.11 Antibody Purification Services Market in North America, 2020-2030: Distribution by Type of Purification Method (USD Billion)
Figure 9.12 Antibody Purification Services Market in North America, 2020-2030: Distribution by Type of Antibody (USD Billion)
Figure 9.13 Antibody Purification Services Market in North America, 2020-2030: Distribution by End User (USD Billion)
Figure 9.14 Antibody Purification Services Market in Europe, 2020-2030 (USD Billion)
Figure 9.15 Antibody Purification Services Market in Europe, 2020-2030: Share of Small Companies (USD Billion)
Figure 9.16 Antibody Purification Services Market in Europe, 2020-2030: Share of Mid-Sized Companies (USD Billion)
Figure 9.17 Antibody Purification Services Market in Europe, 2020-2030: Share of Large / Very Large Companies (USD Billion)
Figure 9.18 Antibody Purification Services Market in Europe, 2020-2030: Distribution by Type of Purification Method (USD Billion)
Figure 9.19 Antibody Purification Services Market in Europe, 2020-2030: Distribution by Type of Antibody (USD Billion)
Figure 9.20 Antibody Purification Services Market in Europe, 2020-2030: Distribution by End User (USD Billion)
Figure 9.21 Antibody Purification Services Market in Asia Pacific, 2020-2030 (USD Billion)
Figure 9.22 Antibody Purification Services Market in Asia Pacific, 2020-2030: Share of Small Companies (USD Billion)
Figure 9.23 Antibody Purification Services Market in Asia Pacific, 2020-2030: Share of Mid-Sized Companies (USD Billion)
Figure 9.24 Antibody Purification Services Market in Asia Pacific, 2020-2030: Share of Large / Very Large Companies (USD Billion)
Figure 9.25 Antibody Purification Services Market in Asia Pacific, 2020-2030: Distribution by Type of Purification Method (USD Billion)
Figure 9.26 Antibody Purification Services Market in Asia Pacific, 2020-2030: Distribution by Type of Antibody (USD Billion)
Figure 9.27 Antibody Purification Services Market in Asia Pacific, 2020-2030: Distribution by End User (USD Billion)
Figure 9.28 Antibody Purification Services Market in Latin America, 2020-2030 (USD Billion)
Figure 9.29 Antibody Purification Services Market in Latin America, 2020-2030: Share of Small Companies (USD Billion)
Figure 9.30 Antibody Purification Services Market in Latin America, 2020-2030: Share of Mid-Sized Companies (USD Billion)
Figure 9.31 Antibody Purification Services Market in Latin America, 2020-2030: Share of Large / Very Large Companies (USD Billion)
Figure 9.32 Antibody Purification Services Market in Latin America, 2020-2030: Distribution by Type of Purification Method (USD Billion)
Figure 9.33 Antibody Purification Services Market in Latin America, 2020-2030: Distribution by Type of Antibody (USD Billion)
Figure 9.34 Antibody Purification Services Market in Latin America, 2020-2030: Distribution by End User (USD Billion)
Figure 9.35 Antibody Purification Services Market in Middle East and North Africa, 2020-2030 (USD Billion)
Figure 9.36 Antibody Purification Services Market in Middle East and North Africa, 2020-2030: Share of Small Companies (USD Billion)
Figure 9.37 Antibody Purification Services Market in Middle East and North Africa, 2020-2030: Share of Mid-Sized Companies (USD Billion)
Figure 9.38 Antibody Purification Services Market in Middle East and North Africa, 2020-2030: Share of Large / Very Large Companies (USD Billion)
Figure 9.39 Antibody Purification Services Market in Middle East and North Africa, 2020-2030: Distribution by Type of Purification Method (USD Billion)
Figure 9.40 Antibody Purification Services Market in Middle East and North Africa, 2020-2030: Distribution by Type of Antibody (USD Billion)
Figure 9.41 Antibody Purification Services Market in Middle East and North Africa, 2020-2030: Distribution by End User (USD Billion)
Figure 10.1 Antibody Contract Manufacturers: Distribution by Year of Establishment
Figure 10.2 Antibody Contract Manufacturers: Distribution by Number of Employees
Figure 10.3 Antibody Contract Manufacturers: Distribution by Company Size
Figure 10.4 Antibody Contract Manufacturers: Distribution by Scale of Operation
Figure 10.5 Antibody Contract Manufacturers: Distribution by Location of Headquarters (Region-wise)
Figure 10.6 Antibody Contract Manufacturers: Distribution by Type of Antibody Manufactured
Figure 10.7 Antibody Contract Manufacturers: Distribution by Type of Antibody Manufactured and Geographical Location
Figure 10.8 Antibody Contract Manufacturers: Distribution by Type of Antibody and Company Size
Figure 10.9 Antibody Contract Manufacturers: Distribution by Type of Expression System Used
Figure 10.10 Antibody Contract Manufacturers: Distribution by Regulatory Accreditations / Certifications
Figure 11.1 Concluding Remarks: Market Landscape of Antibody Purification Service Providers
Figure 11.2 Concluding Remarks: Geographical Distribution of Antibody Purification Service Providers
Figure 11.3 Concluding Remarks: Regional Capabilities
Figure 11.4 Concluding Remarks: Demand Analysis
Figure 11.5 Concluding Remarks: Market Forecast and Opportunity Analysis
Figure 11.6 Concluding Remarks: Market Landscape of Antibody Contract Manufacturing Organizations
 

List Of Tables

Table 3.1 Ligands Used for Class-Specific Affinity Antibody Purification
Table 4.1 List of Antibody Purification Service Providers
Table 4.2 List of Additional Antibody Purification Service Providers
Table 4.3 Antibody Purification Service Providers: Information on Type of Antibody Purified
Table 4.2 Antibody Purification Service Providers: Information on Source of Antibody
Table 4.4 Antibody Purification Service Providers: Information on Type of Purification Method
Table 4.5 Antibody Purification Service Providers: Information on Type of Physio Chemical Antibody Purification Method
Table 4.6 Antibody Purification Service Providers: Information on Type of Class Specific Antibody Purification Method
Table 4.7 Antibody Purification Service Providers: Information on Application Area
Table 4.8 Antibody Purification Service Providers: Information on End User
Table 6.1 Antibody Purification Services List of Profiled Companies
Table 6.2 Antibody Research: Company Snapshot
Table 6.3 Antibody Research: Antibody Purification Service Portfolio
Table 6.4 Bio-synthesis: Company Snapshot
Table 6.5 Bio-synthesis: Antibody Purification Service Portfolio
Table 6.6 Genscript Biotech: Company Snapshot
Table 6.7 Genscript Biotech: Antibody Purification Service Portfolio
Table 6.8 Genscript Biotech: Recent Developments and Future Outlook
Table 6.9 ProSci : Company Snapshot
Table 6.10 ProSci: Antibody Purification Service Portfolio
Table 6.11 ProSci : Recent Developments and Future Outlook
Table 6.12 QED Bioscience: Company Snapshot
Table 6.13 QED Bioscience: Antibody Purification Service Portfolio
Table 6.14 QED Bioscience: Recent Developments and Future Outlook
Table 6.15 SouthernBiotech: Company Snapshot
Table 6.16 SouthernBiotech: Antibody Purification Service Portfolio
Table 6.17 SouthernBiotech: Recent Developments and Future Outlook
Table 6.18 Thermo Fisher Scientific : Company Snapshot
Table 6.19 Thermo Fisher Scientific : Antibody Purification Service Portfolio
Table 6.20 Thermo Fisher Scientific: Recent Developments and Future Outlook
Table 6.21 Virusys: Company Snapshot
Table 6.22 Virusys: Antibody Purification Service Portfolio
Table 6.23 2BScientific: Company Snapshot
Table 6.24 2BScientific: Antibody Purification Service Portfolio
Table 6.25 2BScientific: Recent Developments and Future Outlook
Table 6.26 BBI Solutions: Company Snapshot
Table 6.27 BBI Solutions: Antibody Purification Service Portfolio
Table 6.28 BBI Solutions: Recent Developments and Future Outlook
Table 6.29 Covalab: Company Snapshot
Table 6.30 Covalab: Antibody Purification Service Portfolio
Table 6.31 Covalab: Recent Developments and Future Outlook
Table 6.32 RD-Biotech: Company Snapshot
Table 6.33 RD-Biotech: Antibody Purification Service Portfolio
Table 6.34 RD-Biotech: Recent Developments and Future Outlook
Table 6.35 Allele Life Sciences: Company Snapshot
Table 6.36 Allele Life Sciences: Antibody Purification Service Portfolio
Table 6.37 Allele Life Sciences: Recent Developments and Future Outlook
Table 6.38 Detai Bio-Tech: Company Snapshot
Table 6.39 Detai Bio-Tech: Antibody Purification Service Portfolio
Table 6.40 Syngene: Company Snapshot
Table 6.41 Syngene: Antibody Purification Service Portfolio
Table 6.42 Syngene: Recent Developments and Future Outlook
Table 10.1 List of Antibody Contract Manufacturers
Table 10.2 Antibody Contract Manufacturers: Information on Scale of Operation
Table 10.3 Antibody Contract Manufacturers: Information on Type of Antibodies Manufactured
Table 10.4 Antibody Contract Manufacturers: Information on Expression Systems Used
Table 10.5 Antibody Contract Manufacturers: Information on Regulatory Accreditations / Certifications
Table 13.1 Antibody Purification Service Providers: Distribution by Year of Establishment
Table 13.2 Antibody Purification Service Providers: Distribution by Company Size
Table 13.3 Antibody Purification Service Providers: Distribution by Location of Headquarters
Table 13.4 Antibody Purification Service Providers: Distribution by Geography
Table 13.5 Antibody Purification Service Providers: Distribution by Availability of Contract Manufacturing Services
Table 13.6 Antibody Purification Service Providers: Distribution by Type of Antibody Purified
Table 13.7 Antibody Purification Service Providers: Distribution by Source of Antibody
Table 13.8 Antibody Purification Service Providers: Distribution by Type of Purification Method
Table 13.9 Antibody Purification Service Providers: Distribution by Type of Physio Chemical Antibody Purification Method
Table 13.10 Antibody Purification Service Providers: Distribution by Type of Class-Specific Purification Method
Table 13.11 Antibody Purification Service Providers: Distribution by Application Area
Table 13.12 Antibody Purification Service Providers: Distribution by End User
Table 13.13 Antibody Purification Service Providers: Distribution by Type of Antibody and End User
Table 13.14 Thermo Fisher Scientific: Annual Revenues, FY 2015-Q3 2020 (USD Billion)
Table 13.15 Syngene: Annual Revenues, FY 2016-FY 2020 (INR Billion)
Table 13.16 Antibody Purification Service Providers based in North America: Distribution by Company Size
Table 13.17 Antibody Purification Service Providers based in North America: Distribution by Type of Antibody Purified
Table 13.18 Antibody Purification Service Providers based in North America: Distribution by Type of Antibody Purification Method
Table 13.19 Antibody Purification Service Providers based in North America: Distribution by Application Area
Table 13.20 Antibody Purification Service Providers based in North America: Distribution by Size of the Market (USD Billion)
Table 13.21 Antibody Purification Service Providers based in Europe: Distribution by Company Size
Table 13.22 Antibody Purification Service Providers based in Europe: Distribution by Type of Antibody Purified
Table 13.23 Antibody Purification Service Providers based in Europe: Distribution by Type of Antibody Purification Method
Table 13.24 Antibody Purification Service Providers based in Europe: Distribution by Application Area
Table 13.25 Antibody Purification Service Providers based in Europe: Distribution by Size of the Market (USD Billion)
Table 13.26 Antibody Purification Service Providers based in Asia Pacific and the Rest of the World: Distribution by Company Size
Table 13.27 Antibody Purification Service Providers based in Asia Pacific and the Rest of the World: Distribution by Type of Antibody Purified
Table 13.28 Antibody Purification Service Providers based in Asia Pacific and the Rest of the World: Distribution by Type of Antibody Purification Method
Table 13.29 Antibody Purification Service Providers based in Asia Pacific and the Rest of the World: Distribution by Application Area
Table 13.30 Antibody Purification Service Providers based in Asia Pacific and the Rest of the World: Distribution by Size of the Market (USD Billion)
Table 13.31 Demand Analysis: Annual Demand for Antibodies (in Kilograms)
Table 13.32 Demand Analysis: Distribution by Scale of Operation (in Kilograms)
Table 13.33 Demand Analysis: Distribution by Geographical Location
Table 13.34 Global Antibody Purification Services Market: 2020-2030, Conservative, Base and Optimistic Scenarios (USD Billion)
Figure 13.35 Global Antibody Purification Services Market, 2020-2030: Distribution by Company Size (USD Billion)
Figure 13.36 Global Antibody Purification Services Market, 2020-2030: Distribution by Type of Antibody Purified (USD Billion)
Figure 13.37 Global Antibody Purification Services Market, 2020-2030: Distribution by Purification Method (USD Billion)
Figure 13.38 Global Antibody Purification Services Market, 2020-2030: Distribution by End User (USD Billion)
Figure 13.39 Antibody Purification Services Market, 2020 and 2030: Distribution by Geography (USD Billion)
Table 13.40 Antibody Purification Services Market in North America: 2020-2030, Conservative, Base and Optimistic Scenarios (USD Billion)
Table 14.41 Antibody Purification Services Market in North America, 2020-2030: Share of Small Companies (USD Billion)
Table 14.42 Antibody Purification Services Market in North America, 2020-2030: Share of Mid-Sized Companies (USD Billion)
Table 14.43 Antibody Purification Services Market in North America, 2020-2030: Share of Large / Very Large Companies (USD Billion)
Table 14.44 Antibody Purification Services Market in North America, 2020-2030: Distribution by Type of Purification Method (USD Billion)
Table 14.44 Antibody Purification Services Market in North America, 2020-2030: Distribution by Type of Antibody (USD Billion)
Table 14.45 Antibody Purification Services Market in North America, 2020-2030: Distribution by End User (USD Billion)
Table 14.46 Antibody Purification Services Market in Europe, 2020-2030 (USD Billion)
Table 14.47 Antibody Purification Services Market in Europe, 2020-2030: Share of Small Companies (USD Billion)
Table 14.48 Antibody Purification Services Market in Europe, 2020-2030: Share of Mid-Sized Companies (USD Billion)
Table 14.49 Antibody Purification Services Market in Europe, 2020-2030: Share of Large / Very Large Companies (USD Billion)
Table 14.50 Antibody Purification Services Market in Europe, 2020-2030: Distribution by Type of Purification Method (USD Billion)
Table 14.51 Antibody Purification Services Market in Europe, 2020-2030: Distribution by Type of Antibody (USD Billion)
Table 14.52 Antibody Purification Services Market in Europe, 2020-2030: Distribution by End User (USD Billion)
Table 14.53 Antibody Purification Services Market in Asia Pacific, 2020-2030 (USD Billion)
Table 14.54 Antibody Purification Services Market in Asia Pacific, 2020-2030: Share of Small Companies (USD Billion)
Table 14.55 Antibody Purification Services Market in Asia Pacific, 2020-2030: Share of Mid-Sized Companies (USD Billion)
Table 14.56 Antibody Purification Services Market in Asia Pacific, 2020-2030: Share of Large / Very Large Companies (USD Billion)
Table 14.57 Antibody Purification Services Market in Asia Pacific, 2020-2030: Distribution by Type of Purification Method (USD Billion)
Table 14.58 Antibody Purification Services Market in Asia Pacific, 2020-2030: Distribution by Type of Antibody (USD Billion)
Table 14.59 Antibody Purification Services Market in Asia Pacific, 2020-2030: Distribution by End User (USD Billion)
Table 14.60 Antibody Purification Services Market in Latin America, 2020-2030 (USD Billion)
Table 14.61 Antibody Purification Services Market in Latin America, 2020-2030: Share of Small Companies (USD Billion)
Table 14.62 Antibody Purification Services Market in Latin America, 2020-2030: Share of Mid-Sized Companies (USD Billion)
Table 14.63 Antibody Purification Services Market in Latin America, 2020-2030: Share of Large / Very Large Companies (USD Billion)
Table 14.64 Antibody Purification Services Market in Latin America, 2020-2030: Distribution by Type of Purification Method (USD Billion)
Table 14.65 Antibody Purification Services Market in Latin America, 2020-2030: Distribution by Type of Antibody (USD Billion)
Table 14.66 Antibody Purification Services Market in Latin America, 2020-2030: Distribution by End User (USD Billion)
Table 14.67 Antibody Purification Services Market in Middle East and North Africa, 2020-2030 (USD Billion)
Table 14.68 Antibody Purification Services Market in Middle East and North Africa, 2020-2030: Share of Small Companies (USD Billion)
Table 14.69 Antibody Purification Services Market in Middle East and North Africa, 2020-2030: Share of Mid-Sized Companies (USD Billion)
Table 14.70 Antibody Purification Services Market in Middle East and North Africa, 2020-2030: Share of Large / Very Large Companies (USD Billion)
Table 14.71 Antibody Purification Services Market in Middle East and North Africa, 2020-2030: Distribution by Type of Purification Method (USD Billion)
Table 14.72 Antibody Purification Services Market in Middle East and North Africa, 2020-2030: Distribution by Type of Antibody (USD Billion)
Table 14.73 Antibody Purification Services Market in Middle East and North Africa, 2020-2030: Distribution by End User (USD Billion)
Table 13.74 Antibody Contract Manufacturers: Distribution by Year of Establishment
Table 13.75 Antibody Contract Manufacturers: Distribution by Number of Employees
Table 13.76 Antibody Contract Manufacturers: Distribution by Scale of Operation
Table 13.77 Antibody Contract Manufacturers: Distribution by Location of Headquarters (Region-wise)
Table 13.78 Antibody Contract Manufacturers: Distribution by Type of Antibodies Manufactured
Figure 13.79 Antibody Contract Manufacturers: Distribution by Type of Antibodies Manufactured and Geography
Figure 13.80 Antibody Contract Manufacturers: Distribution by Type of Antibodies and Number of Employees
Table 13.81 Antibody Contract Manufacturers: Distribution by Type of Expression System Used
Table 13.82 Antibody Contract Manufacturers: Distribution by Regulatory Accreditations / Certifications
 

List Of Companies

  1. 2BScientific
  2. AbbVie Contract Manufacturing
  3. Abcam
  4. Abcepta
  5. ABclonal Technology
  6. Abcore
  7. AbGenics Life Sciences
  8. ABL
  9. Abwiz Bio
  10. Abzena
  11. Adaltis
  12. Affinity Biologicals
  13. Affinity Life Sciences
  14. AffinityImmuno
  15. Agarose Bead Technologies
  16. AGC Biologics
  17. Agro-Bio 
  18. Agrisera
  19. Ajinomoto Althea
  20. Alcami
  21. Aldevron
  22. Allele Biotechnology
  23. Allele Life Sciences
  24. Alvotech
  25. Albany Molecular Research (AMRI)
  26. Antibodies Incorporated
  27. Antibody Production Services
  28. Antibody Research 
  29. Antibody Solutions
  30. Arabio
  31. Aragen Bioscience
  32. ARP American Research Products
  33. Artron Laboratories
  34. ATZ Labs
  35. AutekBio
  36. AvantGen
  37. Avantor
  38. Aves Labs
  39. Avid Bioservices
  40. Axcellerate Pharma
  41. Batavia Biosciences
  42. Baxter BioPharma Solutions
  43. BBI Solutions
  44. Bethyl Laboratories
  45. Bhat Bio-tech 
  46. BIBITEC
  47. BINEX
  48. Bio Basic
  49. Bioassay Technology Laboratory
  50. Biocodon Technologies
  51. BioGenes
  52. BioInvent International
  53. Biomatik
  54. Biomay
  55. Bio-Rad
  56. BioServUK
  57. Biosynergy
  58. Bio-Synthesis
  59. BioTechnique
  60. BIOTEM
  61. BioToolomics
  62. Biovian
  63. BioVolutions
  64. BioXcellence
  65. Boehringer Ingelheim
  66. Bon Opus Biosciences
  67. Boster Bio
  68. Burrard Pharmaceuticals
  69. Capra Science Antibodies
  70. Catalent Biologics
  71. CDI Laboratories
  72. CEDARLANE
  73. Cell Culture Company
  74. Celltrion Healthcare
  75. Celonic
  76. Cerbios-Pharma
  77. ChemPartner
  78. CinnaGen
  79. CMAB Biopharma
  80. Cobra Biologics
  81. Covalab
  82. Covance
  83. Creative Biolabs
  84. Creative Diagnostics
  85. CUSABIO
  86. Cytovance Biologics
  87. Davids Biotechnology
  88. DCBiosciences
  89. Detai Bio-tech
  90. Diaclone
  91. Diatec Monoclonals
  92. DM Bio
  93. EirGenix
  94. Elabscience
  95. Emergent BioSolutions
  96. Endocrine Technologies
  97. Envigo
  98. Episentum
  99. Etinpro
  100. EuBiologics
  101. EUPROTEIN
  102. Eurofins
  103. Eurogentec
  104. Evotec
  105. exonbio
  106. FabGennix International
  107. FairJourney Biologics
  108. FiberCell Laboratories
  109. FUJIFILM Diosynth Biotechnologies
  110. G&P Biosciences
  111. Gemini Biosciences
  112. Genei Labs
  113. GeneTex
  114. Geno Technology
  115. GenScript
  116. GenWay Biotech
  117. GlaxoSmithKline
  118. Glenmark
  119. Goodwin Biotechnology
  120. GTP Technology
  121. HALIX
  122. Hong Kong Institute of Biotechnology
  123. HUABIO
  124. IDT Biologika
  125. ImmunoGenes
  126. ImmunoPrecise
  127. Inno Biologics
  128. Innovagen
  129. Interchim
  130. IONTAS
  131. JHL Biotech
  132. KareBay Biochem
  133. KBI Biopharma
  134. Kemwell Biopharma
  135. KMD Bioscience
  136. KUBio
  137. LakePharma
  138. LAMPIRE Biological Laboratories
  139. Laureate Biopharmaceutical Services
  140. Leadgene Biomedical
  141. Leinco Technologies
  142. LFB Biomanufacturing
  143. Lifeline Laboratory
  144. Lofstrand Labs
  145. Lonza
  146. Mabion
  147. MabPlex
  148. Mab-Venture Biopharma
  149. Maine Biotechnology Services
  150. MassBiologics
  151. Medix Biochemica
  152. Menarini Biotech
  153. Merck Millipore
  154. Meridian Life Science
  155. Mimotopes
  156. Mologic
  157. Mycenax Biotech
  158. NanoTools Antibodies
  159. Nitto Avecia Pharma Services
  160. Noble Life Sciences
  161. Northway Biotechpharma
  162. Novasep
  163. Ology Bioservices
  164. Olympic Protein Technologies
  165. Pacific Immunology
  166. Padtan Elm Incorporation
  167. Panoply Bio
  168. PhosphoSolutions
  169. Pierre Fabre
  170. Piramal Pharma Solutions
  171. Polymun Scientific
  172. Precision Antibody
  173. Premas Biotech
  174. ProSpec
  175. Protein Ark 
  176. ProteoGenix
  177. ProSci
  178. PX'Therapeutics
  179. QED Bioscience
  180. R&D Systems
  181. RayBiotech
  182. RD-Biotech
  183. Rentschler Biopharma
  184. Rockland Immunochemicals
  185. SAL Scientific
  186. Sanofi Active Ingredient Solutions
  187. Sartorius
  188. SDIX
  189. SeraCare
  190. Seramun Diagnostica
  191. Shikhar Biotech
  192. Singapore Advanced Biologics
  193. Sirius-biotech 
  194. SouthernBiotech
  195. Syd Labs
  196. Synaptic Systems
  197. Synbio Technologies
  198. Syngene
  199. Takara Bio
  200. The Antibody Company
  201. The Native Antigen Company
  202. Therapure Biomanufacturing
  203. Thermo Fisher Scientific
  204. TNB Laboratories
  205. TransGenic
  206. Virusys 
  207. Viva Biotech
  208. WuXi Biologics

PRICING DETAILS

USD 5,499

This license grants the right of use of the purchased report to a single recipient only (normally the person who buys the report). You may access the material on your computer, as and when required, for your own personal use. You may also print read more

This license grants the right of use of the purchased report by the employees of a business unit at a particular site/office location. The report may be accessed on the computer of any employee within the business unit. You may also print multiple read more

This license entitles the buyer of the report to share, distribute the report (either full or in part) with other employees of the same firm/enterprise. The report may be accessed by any employee of the enterprise and there is no limit on the read more

Discounts available for multiple report purchases
sales@rootsanalysis.com